Stifel Maintains The Scotts Miracle(SMG.US) With Hold Rating, Maintains Target Price $78
Stifel Maintains The Scotts Miracle(SMG.US) With Hold Rating, Raises Target Price to $78
Scotts Miracle-Gro Is Maintained at Overweight by Wells Fargo
Scotts Miracle Gro Analyst Ratings
Wells Fargo Maintains The Scotts Miracle(SMG.US) With Buy Rating, Cuts Target Price to $85
Truist Financial Maintains The Scotts Miracle(SMG.US) With Hold Rating
UBS Maintains The Scotts Miracle(SMG.US) With Hold Rating, Cuts Target Price to $77
Scotts Miracle-Gro Is Maintained at Hold by Truist Securities
Scotts Miracle Gro Analyst Ratings
Truist Financial Maintains The Scotts Miracle(SMG.US) With Hold Rating, Announces Target Price $90
Wells Fargo Maintains The Scotts Miracle(SMG.US) With Buy Rating, Raises Target Price to $95
UBS Maintains The Scotts Miracle(SMG.US) With Hold Rating, Raises Target Price to $90
Truist Financial Maintains The Scotts Miracle(SMG.US) With Hold Rating
Scotts Miracle Gro Analyst Ratings
Scotts Miracle Gro Analyst Ratings
Wells Fargo Maintains The Scotts Miracle(SMG.US) With Buy Rating, Raises Target Price to $85
Truist Financial Maintains The Scotts Miracle(SMG.US) With Hold Rating
Wells Fargo Cuts Price Target on Scotts Miracle-Gro to $75 From $83, Maintains Overweight Rating
Scotts Miracle Gro Analyst Ratings
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $75